Successful use of an antithrombin for heparin resistance with andexanet alfa
JA Clin Rep
.
2023 May 17;9(1):26.
doi: 10.1186/s40981-023-00619-7.
Authors
Jun Honda
1
,
Yuya Itakura
2
,
Shiori Tanaka
2
,
Satoki Inoue
2
Affiliations
1
Department of Anesthesiology, Fukushima Medical University Hospital, 1 Hikarigaoka, Fukushima, 960-1295, Japan. j.honda1984@gmail.com.
2
Department of Anesthesiology, Fukushima Medical University Hospital, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
PMID:
37193808
PMCID:
PMC10188801
DOI:
10.1186/s40981-023-00619-7
No abstract available
Keywords:
Activated coagulation time; Andexanet alfa; Antithrombin; Edoxaban; Heparin resistance.
Publication types
Letter